Document Detail


Health and cost benefits associated with the use of metoprolol in heart attack patients.
MedLine Citation:
PMID:  25231274     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Heart attack (myocardial infarction) is a highly prevalent entity worldwide. Widespread implementation of reperfusion strategies has dramatically reduced the mortality associated with infarction. Paradoxically, the mortality reduction has significantly increased the incidence of chronic heart failure (HF). Treatment of HF, once present, represents a huge socioeconomic burden on individuals and healthcare systems. The possibility of preventing rather than treating post-infarction HF would be of paramount importance. Given that infarct size is the main determinant of adverse post-infarction outcomes (including chronic HF), therapies able to reduce infarct size are needed. The single administration of intravenous metoprolol before reperfusion has been recently shown to reduce infarct size and reduce the cases of chronic HF in a proof-of-concept trial. If confirmed in larger trials, this low-cost therapy is expected to have a major health and socioeconomic impact.
Authors:
Rodrigo Fernández-Jiménez; Borja Ibanez
Related Documents :
22719074 - Overexpression of microrna-1 impairs cardiac contractile function by damaging sarcomere...
25222954 - An innovative adaptive control strategy for sensorized left ventricular assist devices.
25179484 - Macroscopic morphology of right atrial appendage in human.
25365554 - Bioartificial heart: a human-sized porcine model - the way ahead.
22408034 - Effects of celecoxib on restenosis after coronary intervention and evolution of atheros...
16901054 - Early wear development in a novel mechanical heart valve prosthesis made from polymeric...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-18
Journal Detail:
Title:  Expert review of clinical pharmacology     Volume:  -     ISSN:  1751-2441     ISO Abbreviation:  Expert Rev Clin Pharmacol     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101278296     Medline TA:  Expert Rev Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-3     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of microRNA-29b in angiotensin II-induced epithelial-mesenchymal transition in renal tubular ep...
Next Document:  Local manganese chloride treatment accelerates fracture healing in a rat model.